{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:04:47Z","timestamp":1759334687718,"version":"build-2065373602"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T00:00:00Z","timestamp":1676505600000},"content-version":"am","delay-in-days":352,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.jfo.2021.05.012","type":"journal-article","created":{"date-parts":[[2022,1,19]],"date-time":"2022-01-19T12:44:54Z","timestamp":1642596294000},"page":"331-337","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trends in prescriptions for glaucoma and ocular hypertension in France between 2014 and 2019"],"prefix":"10.1016","volume":"45","author":[{"given":"E.","family":"O'Shaughnessy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.R.","family":"F\u00e9nolland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-M.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.-P.","family":"Renard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jfo.2021.05.012_bib0105","doi-asserted-by":"crossref","first-page":"e0227595","DOI":"10.1371\/journal.pone.0227595","article-title":"Prescribing trends of glaucoma drugs in six major cities of China from 2013 to 2017","volume":"15","author":"Yu","year":"2020","journal-title":"PloS One"},{"key":"10.1016\/j.jfo.2021.05.012_bib0110","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1016\/j.ophtha.2014.05.013","article-title":"Global prevalence of glaucoma and projections of glaucoma burden through 2040: a systematic review and meta-analysis","volume":"121","author":"Tham","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.05.012_bib0115","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1136\/bjophthalmol-2017-311258","article-title":"Prevalence and causes of vision loss in high-income countries and in Eastern and Central Europe in 2015: magnitude, temporal trends and projections","volume":"102","author":"Bourne","year":"2018","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0120","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/112067219600600107","article-title":"Epidemiology of glaucoma in northern Europe","volume":"6","author":"Ringvold","year":"1996","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0125","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","article-title":"Reduction of intraocular pressure and glaucoma progression: results from the early manifest glaucoma trial","volume":"120","author":"Heijl","year":"2002","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0130","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/S0140-6736(17)31469-1","article-title":"Glaucoma","volume":"390","author":"Jonas","year":"2017","journal-title":"The Lancet"},{"key":"10.1016\/j.jfo.2021.05.012_bib0135","first-page":"784","article-title":"Medscape. Baseline factors predicting the risk of conversion from ocular hypertension to primary open-angle glaucoma during a 10-year follow-up","volume":"30","author":"Salvetat","year":"2016","journal-title":"Eye Lond Engl"},{"key":"10.1016\/j.jfo.2021.05.012_bib0140","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1136\/bjophthalmol-2015-307223","article-title":"Global variations and time trends in the prevalence of primary open angle glaucoma (POAG): a systematic review and meta-analysis","volume":"100","author":"Kapetanakis","year":"2016","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0145","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1136\/bjophthalmol-2019-314206","article-title":"Prevalence of treatment with glaucoma medication in Scotland, 2010-2017","volume":"104","author":"Rotchford","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0150","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/S0140-6736(18)32213-X","article-title":"Selective laser trabeculoplasty versus eye drops for first-line treatment of ocular hypertension and glaucoma (LiGHT): a multicentre randomised controlled trial","volume":"393","author":"Gazzard","year":"2019","journal-title":"Lancet Lond Engl"},{"key":"10.1016\/j.jfo.2021.05.012_bib0155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.3129\/i08-076","article-title":"Multicenter study of compliance and drop administration in glaucoma","volume":"43","author":"Kholdebarin","year":"2008","journal-title":"Can J Ophthalmol J Can Ophtalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0160","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1016\/j.ophtha.2010.03.040","article-title":"Videotaped evaluation of eyedrop instillation in glaucoma patients with visual impairment or moderate to severe visual field loss","volume":"117","author":"Hennessy","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.05.012_bib0165","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.ophtha.2015.03.026","article-title":"The most common barriers to glaucoma medication adherence: a cross-sectional survey","volume":"122","author":"Newman-Casey","year":"2015","journal-title":"Ophthalmology"},{"key":"10.1016\/j.jfo.2021.05.012_bib0170","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1136\/bjo.2005.081224","article-title":"The number of people with glaucoma worldwide in 2010 and 2020","volume":"90","author":"Quigley","year":"2006","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0175","doi-asserted-by":"crossref","first-page":"6509809","DOI":"10.1155\/2016\/6509809","article-title":"Medical management of glaucoma in the 21st century from a canadian perspective","volume":"2016","author":"Harasymowycz","year":"2016","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0180","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2165\/00002512-200724120-00004","article-title":"Use of fixed-dose combination drugs for the treatment of glaucoma","volume":"24","author":"Khouri","year":"2007","journal-title":"Drugs Aging"},{"key":"10.1016\/j.jfo.2021.05.012_bib0185","doi-asserted-by":"crossref","first-page":"5901537","DOI":"10.1155\/2020\/5901537","article-title":"Influence of cost of care and adherence in glaucoma management: an update","volume":"2020","author":"Meier-Gibbons","year":"2020","journal-title":"J Ophthalmol"},{"key":"10.1016\/j.jfo.2021.05.012_bib0190","first-page":"40","article-title":"In vitro and in vivo experimental studies on trabecular meshwork degeneration induced by benzalkonium chloride (an American Ophthalmological Society thesis)","volume":"110","author":"Baudouin","year":"2012","journal-title":"Trans Am Ophthalmol Soc"},{"key":"10.1016\/j.jfo.2021.05.012_bib0195","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.preteyeres.2010.03.001","article-title":"Preservatives in eyedrops: the good, the bad and the ugly","volume":"29","author":"Baudouin","year":"2010","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/j.jfo.2021.05.012_bib0200","doi-asserted-by":"crossref","first-page":"e876","DOI":"10.1111\/aos.14410","article-title":"Preservative-free versus preserved glaucoma eye drops and occurrence of glaucoma surgery. A retrospective study based on the French national health insurance information system, 2008-2016","volume":"98","author":"Chamard","year":"2020","journal-title":"Acta Ophthalmol"}],"container-title":["Journal Fran\u00e7ais d'Ophtalmologie"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221004666?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0181551221004666?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T19:17:54Z","timestamp":1759259874000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0181551221004666"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S0181551221004666"],"URL":"https:\/\/doi.org\/10.1016\/j.jfo.2021.05.012","relation":{},"ISSN":["0181-5512"],"issn-type":[{"type":"print","value":"0181-5512"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in prescriptions for glaucoma and ocular hypertension in France between 2014 and 2019","name":"articletitle","label":"Article Title"},{"value":"Journal Fran\u00e7ais d'Ophtalmologie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jfo.2021.05.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}